Patient Safety
To ensure the safety of all of Dar Aldawa’s medicines, we hold and maintain an active pharmacovigilance program. Our commitment to pharmacovigilance aims to focus on the safety and well-being of our patients which has always been and shall remain our utmost priority.
Pharmacovigilance activities include the detection, assessment, understanding and prevention of adverse effects or any other drug related problems.
In order to ensure fulfillment of our pharmacovigilance activities, please report any adverse drug reactions or drug related problem related to any of Dar Aldawa's products.
What should I report?
• Adverse drug reactions
• Lack of efficacy
• Overdose, abuse, misuse, off-label use
• Use of drug during pregnancy and breastfeeding
• Quality defects, or counterfeits
• Medication errors
• Drug interactions
• Occupational exposure
To report any side effects or problems related to the use of any of Dar Aldawa's products, please contact us
Please enable JavaScript in your browser to complete this form.
Contact Dar Aldawa through any of the following methods depending on your location